Related Experiment Videos
Isolation and characterization of one soluble and two membrane-associated forms of phosphoinositide-specific
J J Baldassare1, P A Henderson, G J Fisher
1American Red Cross, St. Louis, Missouri 63108.
Abstract:
Two forms (mPLC-I, mPLC-II) of phosphoinositide-specific phospholipase C have been purified, 1494- and 1635-fold, respectively, from plasma membranes of human platelets. Purified mPLC-I and mPLC-II had estimated molecular weights by gel filtration and sodium dodecyl sulfate-polyacrylamide gels of 69,000 and 63,000, respectively. Two cytosolic forms (PLC-I and PLC-II) of phosphoinositide-specific phospholipase C were also resolved on a phenyl-Sepharose column. The major cytosolic form present in outdated platelets, PLC-II, was purified to homogeneity by chromatography on Fast Q-Sepharose, cellulose phosphate, heparin-agarose, phenyl-Sepharose, Superose 12, DEAE-5PW, and hydroxylapatite. Purified PLC-II had a molecular weight of 57,000 on sodium dodecyl sulfate-polyacrylamide gels. mPLC-I, mPLC-II, and PLC-II hydrolyzed both PI and PIP2. The Vmax for PIP2 hydrolysis was similar for all three forms of PLC and was approximately 5-fold greater than for PI hydrolysis. The Km for PIP2 hydrolysis was also similar for the three enzymes. In contrast, the Km for PI hydrolysis by PLC-II was 10-fold lower than by mPLC-I and mPLC-II. In addition, antibody prepared against PLC-II did not cross-react with either mPLC-I or mPLC-II. These data indicate that platelets contain membrane-associated phosphoinositide-specific phospholipases C that are distinct from at least one cytosolic form (PLC-II) of the enzyme.
Insights
Human platelets contain distinct membrane-associated and cytosolic forms of phosphoinositide-specific phospholipase C (PLC). These enzymes, including membrane-associated mPLC-I, mPLC-II, and cytosolic PLC-II, show varied substrate affinities and are immunologically distinct.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Phosphoinositide-specific phospholipase C (PLC) enzymes play critical roles in cellular signaling pathways.
- Platelets are key participants in hemostasis and thrombosis, with PLC activity influencing their function.
Purpose of the Study:
- To purify and characterize membrane-associated and cytosolic forms of phosphoinositide-specific phospholipase C (PLC) from human platelets.
- To investigate the enzymatic properties and immunological relationships between different PLC isoforms in platelets.
Main Methods:
- Purification of membrane-associated (mPLC-I, mPLC-II) and cytosolic (PLC-II) forms of PLC from human platelets using various chromatography techniques.
- Determination of molecular weights via gel filtration and SDS-PAGE.
- Enzymatic assays to measure hydrolysis of phosphatidylinositol (PI) and phosphatidylinositol 4,5-bisphosphate (PIP2), including Vmax and Km determination.
- Generation of antibodies against PLC-II for cross-reactivity studies.
Main Results:
- Two membrane-associated PLC forms (mPLC-I, mPLC-II) and a major cytosolic form (PLC-II) were purified.
- All purified forms hydrolyzed PI and PIP2, with similar Vmax for PIP2 hydrolysis and higher activity towards PIP2 than PI.
- PLC-II exhibited a significantly lower Km for PI hydrolysis compared to mPLC-I and mPLC-II, indicating distinct substrate preferences.
- Antibodies against PLC-II did not cross-react with mPLC-I or mPLC-II, demonstrating their immunological distinctness.
Conclusions:
- Human platelets possess distinct membrane-associated and cytosolic forms of phosphoinositide-specific phospholipase C.
- These isoforms differ in their substrate kinetics and are immunologically unrelated, suggesting specialized roles in platelet signaling.